Original document(6 pages)  中文版
    The present invention relates to a resuscitantanaleptic medicine for general anesthesia. It is formed from nanmu tree bark alkaloid intravenous injection composed of namu tree bark alkaloid and water or intramuscular injection, its namu tree bark alkaloid concentration is 2mg/ml-10mg/ml, in which the namu tree bark is undergone the processes of drying, pulverizing, extracting with chloroform, and recovering chloroform to obtain its extract, i,e, numu tree bark alkaloid. Said resuscitantanaleptic medicine can produce antagonism for general anesthesia, respiration and circulation inhibition action produced by general anesthetic through GABAergic nerve. It possesses the advantages of reliable effect and less side effect.
Application Number
申请号
02133578 Application Date
申请日
2002.08.05
Title 名称 General anesthesia resuscitantanaleptic medicine
Publication Number
公开号
1394639 Publication Date
公开日
2003.02.05
Approval Pub. Date Granted Pub. Date
International Classification 分类号 A61K31/47,A61K35/78,A61P43/00
Applicant(s) Name
申请人
Liu Bin
Address 地址 610041
Inventor(s) Name 发明人 Liu Bin
Attorney & Agent 代理人
More information 更  多  信  息


 Related patents information
Colour flame candle
Natural iodine-enriching nutritious wheat flour and preparing method thereof
Composite fertilizer producing technology and equipment by dissolving spraying and pelletizing ammonium nitrate
One chip synchronous switcher for comprehensive business digit network switching equipment
Wet oil refining process utilizing waste plastics and its vaporizer
Health care drink containing the dried rhizome of rehmannia and making method thereof
Fast battery hermetization testing method
Radix sileris total chromone extractive and its preparation method
Submerged arc welding flux material used for high grade pipe line steel
Compound ledebouriella pyrimidine and its separating process
Google
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.